Deepak Fertilisers And Petrochemicals Corporation Limited (DEEPAKFERT.NS)
Pune, MA, IN
Deepak Fertilisers And Petrochemicals Corporation Limited operates as an Indian enterprise, specializing in the manufacturing and distribution of a wide array of fertilizers and industrial chemicals. The company's operations are strategically divided into four distinct segments: Chemicals, Bulk Fertilisers, Realty, and Windmill. Within its Chemicals division, the company produces a diverse portfolio of products such as ammonia, methanol, both dilute and concentrated nitric acid, carbon dioxide, technical ammonium nitrate, iso-propyl alcohol, and propane, alongside other bulk and specialized chemical compounds. The Bulk Fertilisers segment focuses on providing crucial agricultural inputs, including nitro phosphate, muriate of potash, various nitrogen phosphorous potassium (NPK) blends, water-soluble fertilisers, bentonite sulphur, diammonium phosphate (DAP), ammonium sulphate, custom mixtures, single super phosphate, sulphur, micronutrients, SSF, and bio-fertilisers. Beyond its core chemical and fertiliser businesses, Deepak Fertilisers engages in real estate activities through its Realty segment and harnesses wind energy to generate electricity via its Windmill segment. The company also maintains a significant international footprint, exporting its products to key markets across the Middle East, Africa, and Southeast Asian countries. Established in 1979, the company's corporate headquarters are located in Pune, India.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.30% | -4.90% | +11.84% | +42.07% | +3.38% | +9.94% | -4.40% | +164.88% | +378.61% | +867.12% | +11,130.16% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 3 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%+36.5% ★ Q1'26: +265.7% (vs Q1'25)
-
EPS growth Chemicals: +11.7%-21.0% Q1'26: -49.7% (vs Q1'25)
-
FCF margin FCF growth · Chemicals: +41.7%-5.7% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals: +7.1%+11.0% ★ Q1'26: +8.3% (vs Q1'25)
-
ROIC Chemicals: +3.4%+7.4% ★ Q1'26: +6.9% (vs Q1'25)
-
Share dilution Chemicals: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×3.37× Q1'26: 4.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2007 actual |
Mar 2008 actual |
Mar 2009 actual |
Mar 2010 actual |
Mar 2011 actual |
Mar 2012 actual |
Mar 2013 actual |
Mar 2014 actual |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 2 Rev. Ana. 2 EPS Ana. |
Mar 2027 2 Rev. Ana. 2 EPS Ana. |
Mar 2028 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
8.73B
est: 8.04B (+8.5%)
|
11.44B
est: 10.53B (+8.7%)
|
14.83B
est: 15.07B (-1.7%)
|
13.29B
est: 14.07B (-5.5%)
|
16.28B
est: 15.90B (+2.4%)
|
24.11B
est: 21.50B (+12.2%)
|
26.73B
est: 26.14B (+2.3%)
|
39.15B
est: 35.93B (+8.9%)
|
38.12B
est: 37.48B (+1.7%)
|
43.09B
est: 42.33B (+1.8%)
|
41.50B
est: 42.68B (-2.8%)
|
60.02B
est: 55.97B (+7.2%)
|
67.42B
est: 65.07B (+3.6%)
|
46.85B
est: 52.83B (-11.3%)
|
51.33B
est: 51.54B (-0.4%)
|
65.54B
est: 75.50B (-13.2%)
|
87.00B
est: 106.84B (-18.6%)
|
70.98B
est: 85.82B (-17.3%)
|
84.31B
est: 99.05B (-14.9%)
|
109.76B
107.83B – 111.69B
+10.8% YoY
|
120.27B
116.75B – 123.79B
+9.6% YoY
|
130.30B
124.81B – 135.79B
+8.3% YoY
|
| EBITDA |
1.88B
est: 1.50B (+25.6%)
|
2.38B
est: 451.55M (+427.8%)
|
3.10B
est: 646.47M (+379.2%)
|
3.53B
est: 603.42M (+484.4%)
|
3.59B
est: 698.36M (+413.9%)
|
4.25B
est: 905.31M (+369.5%)
|
3.44B
est: 1.11B (+210.5%)
|
5.50B
est: 1.55B (+255.9%)
|
3.30B
est: 1.58B (+108.6%)
|
4.33B
est: 1.18B (+267.0%)
|
4.87B
est: 1.99B (+144.8%)
|
5.67B
est: 10.41B (-45.5%)
|
5.11B
est: 12.10B (-57.8%)
|
5.42B
est: 9.84B (-44.9%)
|
9.67B
est: 9.58B (+0.9%)
|
13.87B
est: 14.04B (-1.2%)
|
22.29B
est: 1.83B (+1,118.5%)
|
13.96B
est: 16.00B (-12.7%)
|
19.98B
est: 20.76B (-3.7%)
|
23.00B
22.60B – 23.41B
+10.8% YoY
|
25.21B
24.47B – 25.94B
+9.6% YoY
|
27.31B
26.16B – 28.46B
+8.3% YoY
|
| EBIT |
1.42B
est: 1.22B (+16.2%)
|
1.87B
est: 434.54M (+329.9%)
|
2.50B
est: 622.11M (+302.5%)
|
2.81B
est: 580.68M (+384.4%)
|
2.80B
est: 672.05M (+316.9%)
|
3.36B
est: 871.19M (+285.8%)
|
2.36B
est: 1.07B (+121.2%)
|
4.36B
est: 1.49B (+193.0%)
|
2.06B
est: 1.52B (+35.1%)
|
3.07B
est: 2.41B (+27.6%)
|
3.52B
est: 2.42B (+45.4%)
|
4.04B
est: 8.50B (-52.5%)
|
3.39B
est: 9.89B (-65.7%)
|
3.29B
est: 8.04B (-59.1%)
|
7.55B
est: 7.83B (-3.6%)
|
11.54B
est: 11.47B (+0.6%)
|
19.90B
est: 3.91B (+408.5%)
|
10.63B
est: 13.07B (-18.7%)
|
15.95B
est: 16.90B (-5.6%)
|
18.73B
18.40B – 19.06B
+10.8% YoY
|
20.52B
19.92B – 21.12B
+9.6% YoY
|
22.23B
21.30B – 23.17B
+8.3% YoY
|
| Net Income |
920.05M
est: 1.22B (-24.4%)
|
1.09B
est: 358.62M (+203.8%)
|
1.37B
est: 513.43M (+166.8%)
|
1.65B
est: 479.24M (+244.8%)
|
1.88B
est: 554.64M (+238.1%)
|
2.12B
est: 719.00M (+194.4%)
|
1.29B
est: 880.29M (+46.9%)
|
2.41B
est: 1.23B (+95.9%)
|
679.88M
est: 1.26B (-45.9%)
|
1.16B
est: 772.02M (+50.6%)
|
1.54B
est: 1.09B (+41.3%)
|
1.63B
est: 3.97B (-59.0%)
|
706.70M
est: 1.31B (-46.0%)
|
872.60M
est: 2.53B (-65.6%)
|
4.00B
est: 1.36B (+193.5%)
|
6.78B
est: 6.00B (+13.0%)
|
12.10B
est: 1.53B (+691.2%)
|
4.53B
est: 3.80B (+19.3%)
|
9.34B
est: 8.96B (+4.2%)
|
9.39B
8.83B – 9.96B
+4.8% YoY
|
12.26B
11.69B – 12.84B
+30.6% YoY
|
16.01B
14.33B – 17.69B
+30.5% YoY
|
| SGA |
7.64B
est: 390.34M (+1,858.0%)
|
9.09B
est: 170.15M (+5,242.3%)
|
11.83B
est: 243.60M (+4,756.5%)
|
10.43B
est: 227.37M (+4,486.4%)
|
734.40M
est: 263.15M (+179.1%)
|
1.07B
est: 341.13M (+213.7%)
|
2.52B
est: 417.66M (+502.6%)
|
3.43B
est: 582.49M (+488.8%)
|
1.75B
est: 596.59M (+193.2%)
|
2.02B
est: 4.34B (-53.5%)
|
2.33B
est: 4.29B (-45.8%)
|
2.67B
est: 2.71B (-1.6%)
|
3.05B
est: 3.15B (-3.3%)
|
3.25B
est: 2.56B (+26.9%)
|
3.78B
est: 2.50B (+51.3%)
|
5.04B
est: 3.66B (+37.8%)
|
6.09B
est: 6.09B (-0.1%)
|
5.47B
est: 4.17B (+31.1%)
|
6.04B
est: 7.92B (-23.7%)
|
8.78B
8.62B – 8.93B
+10.8% YoY
|
9.62B
9.34B – 9.90B
+9.6% YoY
|
10.42B
9.98B – 10.86B
+8.3% YoY
|
| EPS |
10.11
est: 9.64 (+4.9%)
|
11.97
est: 11.48 (+4.3%)
|
15.06
est: 17.85 (-15.6%)
|
18.17
est: 15.63 (+16.2%)
|
20.61
est: 20.40 (+1.0%)
|
23.27
est: 24.66 (-5.6%)
|
14.21
est: 17.24 (-17.6%)
|
26.44
est: 23.54 (+12.3%)
|
7.48
est: 6.79 (+10.2%)
|
12.78
est: 12.73 (+0.4%)
|
16.48
est: 15.25 (+8.1%)
|
17.88
est: 31.51 (-43.3%)
|
7.77
est: 10.37 (-25.1%)
|
9.58
est: 20.07 (-52.3%)
|
41.47
est: 10.82 (+283.3%)
|
60.44
est: 47.60 (+27.0%)
|
97.70
est: 92.80 (+5.3%)
|
35.87
est: 30.00 (+19.6%)
|
73.95
est: 70.97 (+4.2%)
|
74.40
69.93 – 78.87
+4.8% YoY
|
97.15
92.61 – 101.69
+30.6% YoY
|
126.80
113.48 – 140.12
+30.5% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-25 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Sailesh Chimanlal Mehta | Chairman & MD | 386M | male |
| Girish Shah | Executive Vice President of Corporate Marketing & Corporate Communications | — | male |
| Naresh Kumar Pinisetti | Interim President of Human Resources & Corporate Governance | — | male |
| Pandurang Landge | President of Manufacturing (Cluster 1, 2 & NPD) | — | male |
| Rabindra Kumar Purohit | Vice President of Legal, Company Secretary & Compliance Officer | — | male |
| Raghunath Kelkar | President of Industrial Chemical | — | male |
| Romy Sahay | President of Human Resource | — | male |
| Subhash Chand Anand | President & Chief Financial Officer | — | male |
| Suparas Jain | Executive Vice President of Corporate Finance | — | male |
| Tarun Sinha | President of Technical Ammonium Nitrate | — | male |
| Debasish Banerjee | President of Strategic Projects | — | male |
| Yeshil Sailesh Mehta | Executive Director of Mahadhan AgriTech Limited | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DEEPAKFERT.NS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
